Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 5, 2018, Pages 361-369

  Ahlqvist, Emma ^a   Storm, Petter ^a   Käräjämäki, Annemari ^b,c   Martinell, Mats ^d   Dorkhan, Mozhgan ^a   Carlsson, Annelie ^a   Vikman, Petter ^a   Prasad, Rashmi B ^a   Aly, Dina Mansour ^a   Almgren, Peter ^a   Wessman, Ylva ^a   Shaat, Nael ^a   Spégel, Peter ^a,e   Mulder, Hindrik ^a   Lindholm, Eero ^a   Melander, Olle ^a   Hansson, Ola ^a   Malmqvist, Ulf ^f   Lernmark, Åke ^a   Lahti, Kaj ^b,c   Forsén, Tom ^g   Tuomi, Tiinamaija ^g,h,i   Rosengren, Anders H ^a,j   Groop, Leif ^a,i   more..

^a LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^b VAASA CENTRAL HOSPITAL   (Finland)

^c Diabetes Center   (Finland)

^d UPPSALA UNIVERSITY   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CELL FUNCTION; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC COMPLICATION; DIABETIC RETINOPATHY; DISEASE REGISTRY; FEMALE; GENETIC ASSOCIATION; HIGH RISK PATIENT; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN DEFICIENCY; INSULIN RESISTANCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEDEN; CLASSIFICATION; DIABETES MELLITUS; DISEASE EXACERBATION; RISK FACTOR;

ADULT; CLUSTER ANALYSIS; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85042583803     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30051-2     Document Type: Article

References (27)

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387 (2016), 1513–1530.
2. Tuomi, T, Groop, LC, Zimmet, PZ, Rowley, MJ, Knowles, W, Mackay, IR, Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42 (1993), 359–362.
3. Froguel, P, Zouali, H, Vionnet, N, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328 (1993), 697–702.
4. Yamagata, K, Oda, N, Kaisaki, PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384 (1996), 455–458.
5. Reddy, MA, Zhang, E, Natarajan, R, Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58 (2015), 443–455.
6. Brownlee, M, The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005), 1615–1625.
7. Pearson, ER, Flechtner, I, Njolstad, PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355 (2006), 467–477.
8. Lindholm, E, Agardh, E, Tuomi, T, Groop, L, Agardh, CD, Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17 (2001), 983–989.
9. Manjer, J, Carlsson, S, Elmstahl, S, et al. The Malmo Diet and Cancer study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10 (2001), 489–499.
10. Rahmati, K, Lernmark, A, Becker, C, et al. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Clin Lab 54 (2008), 227–235.
11. Tuomi, T, Carlsson, A, Li, H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48 (1999), 150–157.
12. Vaziri-Sani, F, Delli, AJ, Elding-Larsson, H, et al. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods 371 (2011), 25–37.
13. Almgren, P, Lindqvist, A, Krus, U, et al. Genetic determinants of circulating GIP and GLP-1 concentrations. JCI insight, 2, 2017, 93306.
14. Levey, AS, Stevens, LA, Schmid, CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
15. Martinell, M, Dorkhan, M, Stalhammar, J, Storm, P, Groop, L, Gustavsson, C, Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA). J Diabetes Complications 30 (2016), 1456–1461.
16. Levy, JC, Matthews, DR, Hermans, MP, Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998), 2191–2192.
17. Hennig, C, Cluster-wise assessment of cluster stability. Comput Stat Data An 52 (2007), 258–271.
18. Marchini, J, Howie, B, Myers, S, McVean, G, Donnelly, P, A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 (2007), 906–913.
19. Prasad, RB, Groop, L, Genetics of type 2 diabetes—pitfalls and possibilities. Genes 6 (2015), 87–123.
20. Lyssenko, V, Lupi, R, Marchetti, P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117 (2007), 2155–2163.
21. Liu, YL, Reeves, HL, Burt, AD, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun, 5, 2014, 4309.
22. Nguyen, C, Varney, MD, Harrison, LC, Morahan, G, Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62 (2013), 2135–2140.
23. Li, L, Cheng, WY, Glicksberg, BS, et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med, 7, 2015, 311ra174.
24. Groop, L, Ekstrand, A, Forsblom, C, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36 (1993), 642–647.
25. Gnudi, L, Coward, RJ, Long, DA, Diabetic nephropathy: perspective on novel molecular mechanisms. Trends Endocrinol Metab 27 (2016), 820–830.
26. Welsh, GI, Hale, LJ, Eremina, V, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 12 (2010), 329–340.
27. Lee, SH, Wray, NR, Goddard, ME, Visscher, PM, Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 88 (2011), 294–305.